In search of a pediatric cardiac surgeon's 'Holy Grail': The ideal pulmonary conduit

Expert Review of Cardiovascular Therapy

Volumn 4, Issue 6, 2006, Pages 861-870

  Solomon, Neville A G ^a   Pranav, Subaraya K ^a   Jain, Kailash A ^a   Kumar, Madhan ^a   Kulkarni, Chandrasekhar B ^a   Akbari, Jayesh ^a  

^a APOLLO HOSPITALS   (India)

Author keywords

Bioprosthetic conduit; Conduit; Homografts; Percutaneous valves; Pulmonary conduit; Right ventricle pulmonary artery conduit; Tissue engineered valves

Indexed keywords

GLUTARALDEHYDE; OLEIC ACID;

ALLOGRAFT; ARTERY GRAFT; ATTRIBUTABLE RISK; BIOCOMPATIBILITY; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD REGURGITATION; COW; GRAFT FAILURE; GRAFT OCCLUSION; HANCOCK VALVE PROSTHESIS; HEALTH CARE COST; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; IMMUNOGENICITY; JUGULAR VEIN; MORBIDITY; NONHUMAN; PEDIATRIC CARDIOLOGY; PEDIATRIC SURGERY; PERICARDIUM; PULMONARY ARTERY; PULMONARY HYPERTENSION; QUALITY OF LIFE; REOPERATION; REVIEW; SAINT JUDE HEART VALVE PROSTHESIS; SURGICAL TECHNIQUE; SWINE; THROMBOEMBOLISM; TISSUE ENGINEERING; TRICUSPID VALVE; XENOGRAFT;

ANIMALS; BIOPROSTHESIS; CHILD; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VENTRICLES; HUMANS; PULMONARY ARTERY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TISSUE ENGINEERING;

EID: 33845867411     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.4.6.861     Document Type: Review

References (56)

1. Schultz JM, Shen I, Ungerleider RM. Right ventricle-pulmonary artery conduits. In: Sabiston & Spencer Surgery of the Chest. Sellke FW, del Nido PJ, Swanson SJ (Eds). Elsevier Saunders, Philadelphia, PA, USA 2049-2062 (2005).
2. Shaddy RE, Hawkins JA. Immunology and failure of valved allografts in children. Ann. Thorac. Surg. 74, 1271-1275 (2002).
3. Christenson JT, Vala D, Sierra J, Beghetti M, Kalangos A. Blood group incompatibility and acclerated homograft fibrocalcifications. J. Thorac. Cardiovasc. Surg. 127, 242-250 (2004).
4. Stark J, Bull C, Stajevic M, Jothi M, Elliot M, de Leval M. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J. Thorac. Cardiovasc. Surg. 115, 506-516 (1998).
5. Meyns B, Jashari R, Gewillig M et al. Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first. Eur. J. Cardiothorac. Surg. 28, 211-216 (2005).
6. Caldarone CA, McCrindle BW, Van Arsdell GSV et al. Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J. Thorac. Cardiovasc. Surg. 120, 1022-1031 (2000).
7. Dearani JA, Danielson JK, Puga FJ et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann. Thorac. Surg. 75, 399-411 (2003).
8. Forbess JM, Shah AS, St. Louis JD, Jaggers JJ, Ungerleider RM. Cryopreserved homografts in the pulmonary position: determinants of durability. Ann. Thorac. Surg. 71, 54-59 (2001).
9. Niwaya K, Knott-Craig CJ, Lane MM, Chandrasekharan K, Overholt ED, Elkins RC. Cryopreserved homograft valves in the pulmonary position: risk-analysis for intermediate-term failure. J. Thorac. Cardiovasc. Surg. 117, 141-147 (1999).
10. Stark J. The use of valved conduits in pediatric cardiac surgery. Pediatr. Cardiol. 19, 282-288 (1998).
11. Schorn K, Yankah AC, Alexi-Meskhishvili V, Weng Y, Lange PE, Hetzer R. Risk factors for early degeneration of allografts in pulmonary circulation. Eur. J. Cardiothorac. Surg. 11, 62-69 (1997).
12. Sinzobahamvya N, Wetter J, Blaschczok HC, Cho M, Brecher AM, Urban AE. The fate of small-diameter homografts in the pulmonary position. Ann. Thorac. Surg. 72, 2070-2076 (2001).
13. da Costa FDA, Dohmen PM, Duarte D et al. Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. Eur. J. Cardiothorac. Surg. 27, 572-578 (2005).
14. Hawkins JA, Hillman ND, Lambert LM et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparision with standard cryopreserved allografts. J. Thorac. Cardiovasc. Surg. 126, 247-252 (2003).
15. Tavakkol Z, Gelehrter S, Goldberg CS, Bove EL, Devaney EJ, Ohye RG. Superior durability of Synergraft pulmonary allografts compared with standard cryopreserved allografts. Ann. Thorac. Surg. 80, 1610-1614 (2005).
16. Karamlou T, Ungerleider RM, Alsoufi B et al. Oversizing pulmonary homograft conduits does not significantly decrease allograft failure in children. Eur. J. Cardiothorac. Surg. 27, 548-553 (2005).
17. Levine AJ, Miller PA, Stumper OS et al. Early results of right-ventricular-pulmonary artery conduits in patients under 1 year of age. Eur. J. Cardiothorac. Surg. 19, 122-126 (2001).
18. Dittrich S, Alexi-Meskishvili VV, Yankah AC et al. Comparision of porcine xenografts and homografts for pulmonary valve replacement in children. Ann. Thorac. Surg. 70, 717-722 (2000).
19. Pearl JM, Cooper DS, Bove KE, Manning PB. Early failure of the Shelhigh pulmonary valve conduit in infants. Ann. Thorac. Surg. 74, 542-549 (2002).
20. Ishizaka T, Ohye RG, Goldberg CS et al. Premature failure of small-sized Shelhigh No-React porcine pulmonic valve conduit model NR-4000. Eur. J. Cardiothorac. Surg. 23, 715-718 (2003).
21. Boudjemline Y, Beyler C, Bonnet D, Sidi D. Surprising outcome similarities between Contegra bovine jugular vein conduit and Shelhigh No-React porcine valve conduit: role of immunologic reaction. Eur. J. Cardiothorac. Surg. 24, 850-851 (2003).
22. Marianeschi SM, Iacona GM, Seddio F et al. Shelhigh No-React porcine pulmonic valve conduit: a new alternative to the homograft. Ann. Thorac. Surg. 71, 619-623 (2001).
23. Schreiber C, Bauernschmitt R, Augustin N et al. Implantation of a prosthesis mounted inside a self-expandable stent in the pulmonary valvar area without use of cardiopulmonary bypass. Ann. Thorac. Surg. 81, e1-e3 (2006).
24. Gober V, Berdat P, Pavlovic M, Pfammatter JP, Carrel TP. Adverse mid-term outcome following RVOT reconstruction using the Contegra valved bovine jugular vein. Ann. Thorac. Surg. 79, 625-631 (2005).
25. Shebani OS, McGuirk S, Baghai M et al. Right ventricular outflow tract reconstruction using Contegra valved conduit: natural history and conduit performance under pressure. Eur. J. Cardiothorac. Surg. 29, 397-405 (2006).
26. Meyns B, Garsse LV, Boshoff D et al. The Contegra conduit in the right ventricular outflow tract induces supravalvular stenosis. J. Thorac. Cardiovasc. Surg. 128, 834-840 (2004).
27. Tiete AR, Sachweh JS, Roemer U, Kozlik-Feldmann R, Reichart B, Daebritz SH. Right ventricular outflow tract reconstruction with the Contegra bovine jugular vein conduit: a word of caution. Ann. Thorac. Surg. 77, 2151-2156 (2004).
28. Corno AF, Qanadli SD, Sekarski N et al. Bovine valved xenograft in pulmonary position: medium-term follow-up with excellent hemodynamics and freedom from calcification. Ann. Thorac. Surg. 78, 1382-1388 (2004).
29. Dave HH, Kadner A, Berger F et al. Early results of the bovine jugular vein graft used for reconstruction of the right ventricular outflow tract. Ann. Thorac. Surg. 79, 618-624 (2005).
30. Ando M, Imai Y, Takanashi Y, Hoshino S, Seo K, Terada M. Fate of trileaflet equine pericardial extracardiac conduit used for the correction of anomalies having pulmonic ventricle-pulmonary arterial discontinuity. Ann. Thorac. Surg. 64, 154-158 (1997).
31. Chard RB, Kang N, Andrews DR, Nunn GR. Use of the Medtronic Freestyle valve as a right ventricular to pulmonary artery conduit. Ann. Thorac. Surg. 71, S361-S364 (2001).
32. Novick WM, Anic D, Solf AL et al. Medtronic freestyle valve for right ventricular reconstruction in pediatric ross operations. Ann. Thorac. Surg. 77, 1711-1716 (2004).
33. Kanter KR, Fyfe DA, Mahle WT, Forbess JM, Kirshbom PM. Results with the freestyle porcine aortic root for right ventricular outflow tract reconstruction in children. Ann. Thorac. Surg. 76, 1889-1895 (2003).
34. Aupecle B, Serraf A, Belli E et al. Intermediate follow-up of a composite stentless porcine valved conduit of bovine pericardium in the pulmonary circulation. Ann. Thorac. Surg. 74, 127-132 (2002).
35. Haas F, Schreiber C, Horer J, Kostolny M, Holper K, Lange R. Is there a role for mechanical valved conduits in the pulmonary position? Ann. Thorac. Surg. 79, 1662-1667 (2005).
36. Bermudez CA, Dearani JA, Puga FJ et al. Late results of the peel operation for replacement of failing extracardiac conduits. Ann. Thorac. Surg. 77, 881-888 (2004).
37. Isomatsu Y, Shin'oka T, Aoki M et al. Establishing right ventricle-pulmonary artery continuity by autologous tissue: an alternative approach for prosthetic conduit repair. Ann. Thorac. Surg. 78, 173-180 (2004).
38. Nakae S, Kawada M, Kasahara S, Kuroyama N, Hiraishi S, Yoshimura H. Anterior pulmonary translocation without conduit for the repair of truncus arteriosus. Ann. Thorac. Surg. 61, 990-992 (1996).
39. Danton MHD, Barron DJ, Stumper O et al. Repair of truncus arteriosus: a considered approach to right ventricular outflow tract reconstruction. Eur. J. Cardiothorac. Surg. 20, 95-104 (2001).
40. Quintessenza JA, Jacobs JP, Morell VO, Giroud JM, Boucek RJ. Initial experience with a bicuspid polytetrafluoroethylene pulmonary valve in 41 children and adults: a new option for right ventricular outflow tract reconstruction. Ann. Thorac. Surg. 79, 924-931 (2005).
41. Robin J, Martinot S, Curtil A et al. Experimental right ventricle to pulmonary artery discontinuity: outcome of polyurethane valved conduits. J. Thorac. Cardiovasc. Surg. 115, 898-903 (1998).
42. Nikaidoh H. Aortic translocation and biventricular outflow tract reconstruction: a new surgical repair for transposition of great arteries associated with a ventricular septal defect and pulmonary stenosis. J. Thorac. Cardiovasc. Surg. 88, 365-372 (1984).
43. Morell VO, Jacobs JP, Quintessenza JA. Aortic translocation in the management of transposition of great arteries with ventricular septal defect and pulmonary stenosis: results and follow-up. Ann. Thorac. Surg. 79, 2089-2093 (2005).
44. Bonhoeffer P, Boudjemline Y, Qureshi SA et al. Percutaneous insertion of the pulmonary valve. J. Am. Coll. Cardiol. 39, 1664-1669 (2002).
45. Lutter G, Ardehali R, Cremer J, Bonhoeffer P. Percutaneous valve replacement: current state and future prospects. Ann. Thorac. Surg. 78, 2199-2206 (2004).
46. Zhou JQ, Corno AF, Huber CH, Tozzi P, von Segesser LK. Self-expandable valved stent of large size: off-bypass implantation in pulmonary position. Eur. J. Cardiothorac. Surg. 28, 211-216 (2005).
47. Attmann T, Jahnke T, Quaden R et al. Advances in experimental percutaneous pulmonary valve replacement. Ann. Thorac. Surg. 80, 969-975 (2005).
48. Hijazi ZM. Transcatheter valve replacement: a new era of percutaneous cardiac intervention begins. J. Am. Coll. Cardiol. 43, 1088-1089 (2004).
49. Fuchs JR, Nasseri BA, Vacanti JP. Tissue engineering: a 21st century solution to surgical reconstruction. Ann. Thorac. Surg. 72, 577-591 (2001).
50. Leyh RG, Wilhelmi M, Rebe P et al. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann. Thorac. Surg. 75, 1457-1463 (2003).
51. Stock UA, Nagashima M, Khalil PN et al. Tissue-engineered valved conduits in the pulmonary circulation. J. Thorac. Cardiovasc. Surg. 119, 732-740 (2000).
52. Hoerstrup SP, Kadner A, Breymann C et al. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann. Thorac. Surg. 74, 46-52 (2002).
53. Juthier F, Vincentelli A, Gaudric J et al. Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor. J. Thorac. Cardiovasc. Surg. 131, 843-852 (2006).
54. Leyh RG, Wilhelmi M, Rebe P, Ciboutarl S, Haverich A, Mertsching H. Tissue engineering of viable pulmonary arteries for surgical correction of congenital heart defects. Ann. Thorac. Surg. 81, 1466-1471 (2006).
55. Rieder E, Seebacher G, Kasimir MT et al. Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111, 2792-2797 (2005).
56. Hoerstrup SP, Kadner A, Melnitchouk S et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 106, 1143-1150 (2002).